أعرض في EDS

P-051Preliminary clinical and pathologic characteristics of patients treated in second-line (2L) with 25 cycles (Cy) or more of FOLFIRI + Aflibercept (FA)

التفاصيل البيبلوغرافية
العنوان: P-051Preliminary clinical and pathologic characteristics of patients treated in second-line (2L) with 25 cycles (Cy) or more of FOLFIRI + Aflibercept (FA)
المؤلفون: E. Mata Velasco, J.C. Méndez Méndez, I. Macías Declara, N. Martínez-Lago, I. Juez Martel, Nohra Cecilia Rodríguez, J.A. Barrera Ramírez, D. Cacho Lanvin, Monica Corral, O. Donnay, V. Calderero Aragón, Beatriz García-Paredes, M.T. Delgado Urena, Carles Pericay, Beatriz González-Astorga, A. Ruiz Casado, Teresa Macarulla
بيانات النشر: Oxford University Press, 2016.
سنة النشر: 2016
مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Hematology, 03 medical and health sciences, Abstracts, 0302 clinical medicine, Text mining, Second line, 030220 oncology & carcinogenesis, Internal medicine, medicine, FOLFIRI, 030211 gastroenterology & hepatology, business, Aflibercept, medicine.drug
اللغة: English
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a8780e8e97b4a4dd91f8912063669aa
https://europepmc.org/articles/PMC4984099/
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....7a8780e8e97b4a4dd91f8912063669aa
قاعدة البيانات: OpenAIRE
الوصف
الوصف غير متاح.